Ridgeline Discovery Revenue and Competitors
Estimated Revenue & Valuation
- Ridgeline Discovery's estimated annual revenue is currently $12.1M per year.
- Ridgeline Discovery's estimated revenue per employee is $155,000
Employee Data
- Ridgeline Discovery has 78 Employees.
- Ridgeline Discovery grew their employee count by 42% last year.
Ridgeline Discovery's People
| Name | Title | Email/Phone |
|---|
Ridgeline Discovery Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.3M | 92 | 37% | N/A | N/A |
#2 | $12.1M | 57 | -11% | N/A | N/A |
#3 | $61.7M | 398 | 21% | N/A | N/A |
#4 | $12.2M | 79 | 16% | N/A | N/A |
#5 | $10.2M | 57 | 6% | N/A | N/A |
#6 | $12.1M | 78 | 42% | N/A | N/A |
What Is Ridgeline Discovery?
Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.
keywords:N/A
N/A
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
42%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Basel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 78 | 26% | N/A |
#2 | N/A | 80 | 31% | N/A |
#3 | $17.8M | 81 | 47% | N/A |
#4 | $18.4M | 81 | 21% | N/A |
#5 | N/A | 82 | 0% | N/A |